Faeth Therapeutics, Inc. Common Stock (FTH) is a publicly traded the market company. As of October 24, 2026, FTH trades at $17.08 with a market cap of $519.39M and a P/E ratio of 0.00. FTH moved -16.42% today. Year to date, FTH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $13.43 to $42.14. Analyst consensus is strong buy with an average price target of $56.92. Rallies surfaces FTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks FTH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $17.08 |
| Market Cap | $519.39M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.14 |
| 52-Week Low | $13.43 |
| Volume | 333.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
13 analysts cover FTH: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.92.